Trial Profile
Safety, pharmacokinetic, pharmacodynamic and efficacy of multiple doses of subcutaneous AMG 181 in patients with mild to moderate ulcerative colitis
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2014
Price :
$35
*
At a glance
- Drugs Abrilumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 01 Sep 2014 New trial record